Explore the full management transaction log of DuPont de Nemours, Inc., a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Chemicals & Materials sector, DuPont de Nemours, Inc. has logged 135 public disclosures. Market capitalisation: €16.4bn. The latest transaction was filed on 2 June 2022 (Attribution). Among the most active insiders: Kemp Jon D.. The full history is openly available.
0 of 0 declarations
DuPont de Nemours, Inc. (NYSE: DD) is a U.S.-based industrial company headquartered in Wilmington, Delaware, United States, focused on advanced materials, specialty chemicals, and application-driven solutions for demanding end markets. Its corporate heritage traces back to 1802, giving the company one of the deepest industrial legacies in the sector. That long operating history, combined with a strong research-and-development culture, remains central to DuPont’s competitive positioning. The company highlights a global footprint of manufacturing sites, laboratories, technical centers, and innovation hubs across more than 70 countries, with major clusters in North America, Europe, and Asia. ([dupont.com](https://www.dupont.com/content/dupont/amer/us/en/corporate-homepage/about.html?utm_source=openai)) DuPont’s portfolio is built around high-value, performance-oriented technologies rather than commodity chemicals. Core offerings include water purification and treatment solutions such as membranes and ion-exchange resins, healthcare and medical packaging materials, automotive engineered materials, sustainable construction solutions, aerospace materials, printing and packaging technologies, and advanced materials used in electronics and semiconductor manufacturing. The company’s brands are typically differentiated by reliability, durability, process efficiency, and safety, which helps position DuPont as a strategic supplier to industrial customers rather than a mass-market materials producer. ([dupont.com](https://www.dupont.com/content/dupont/amer/us/en/corporate-homepage/about.html?utm_source=openai)) A major strategic theme in 2025 and 2026 has been portfolio transformation. DuPont completed the separation of its electronics business into Qnity and announced the planned divestiture of its Aramids business, signaling a clearer focus on higher-growth areas such as Water and Healthcare. Management has framed these actions as part of a broader effort to simplify the organization, sharpen capital allocation, and improve long-term value creation. Recent company communications also point to shareholder-return initiatives and continued portfolio optimization. ([dupont.com](https://www.dupont.com/news/dupont-announces-effectiveness-of-form-10-registration-statement-for-qnity.html?utm_source=openai)) For French-speaking investors in France, Belgium, and Switzerland, DuPont stands out as a quality cyclical name within the Chemicals & Materials universe. It offers exposure to long-term structural themes including clean water, healthcare, industrial efficiency, advanced electronics, and resilient infrastructure. At the same time, the investment case must be viewed through the lens of execution risk, restructuring complexity, historical liability exposure, and regulatory scrutiny. Listed on the NYSE under DD in the United States, DuPont remains a globally recognized reference in specialty materials rather than a basic-chemicals producer. ([investors.dupont.com](https://www.investors.dupont.com/news-and-media/press-release-details/2026/DuPont-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx?utm_source=openai))